SaaS Pivots, AI Bets, and Green Tech Grabs, with Eyes on Innovation

September 8, 2025

DENVER, Colo., Sep 08, 2025 (247marketnews.com)- Today’s market is teeming with momentum across SaaS pivots, digital disruptors, biotech breakthroughs, and green energy bets. Here’s what’s making waves this morning:

TEN Holdings (NASDAQ:XHLD) is stepping into the SaaS arena with the launch of its Ten Events Pro (Ten Pro) platform, aiming to transform hybrid and virtual event production. The cloud-based system automates complex broadcast tasks and significantly reduces delivery costs, a move CEO Randy Jones called a “defining milestone” for the company.

With a $10M IPO completed in February at $6/share and a $1M share buyback in play, XHLD is banking on SaaS-driven recurring revenue to unlock scale. Investor sentiment is growing more optimistic, with some analysts projecting $8 price targets if execution holds.

Sky Quarry (NASDAQ:SKYQ), a circular economy player focused on asphalt shingle recycling, is gaining traction as ESG investors rotate back into clean tech and waste-to-value strategies. With attention shifting toward U.S. infrastructure reuse and climate-friendly materials, SKYQ is being talked about as a “low-float sleeper” in the sustainability space.

Genprex (NASDAQ:GNPX) is on the move following chatter around its gene therapy candidate REQORSA possibly securing FDA Fast Track designation for combination treatment in non-small cell lung cancer. While no official news has dropped, volume has spiked sharply on preclinical buzz and licensing potential.

Beyond Air (NASDAQ:XAIR) popped in early trading after reiterating plans to submit a new regulatory filing for its LungFit platform for severe respiratory infections. The stock, which has seen volatility in recent quarters, is regaining attention as investors reassess the commercial potential of nitric oxide-based therapies in hospital and home care settings.

Small-cap AI player Next Tech Holdings (NASDAQ:NTHD) is turning heads with early traction in its generative AI tools for customer service automation, which the company says can slash enterprise service desk costs by up to 60%. With a major pilot contract in the financial services sector underway, momentum is building, though the stock remains highly speculative.

Talphera (NASDAQ:TLPH), formerly AcelRx, continues its pivot toward non-opioid pain management solutions, with investors eyeing its recent FDA filing for Niyad, a hemodialysis anticoagulant. Analysts see the shift as a de-risking play, with a focus on hospital-based delivery and healthcare system integration.

PAID EDITORIAL DISCLOSURE: This is a paid editorial communication intended for informational purposes only. 247 is a third-party media provider and has been compensated by one or more featured companies. Please review 247’s Full Disclaimer https://www.247marketnews.com/disclaimer/.

Please go to https://247marketnews.com/ten-holdings-event-solutions/ for additional 247marketnews.com XHLD disclosure. 247 has been paid by Microcap Advisory for providing ongoing XHLD market outreach and other services.

This press release may include technical analysis for informational purposes only and should not be construed as financial or investment advice. Trading stocks involves risks, and readers should consult with their financial advisor before making investment decisions.

About 24/7 Market News
As a pioneer in digital financial market media, 24/7 Market News (24/7MN) is dedicated to the swift distribution of financial market news and information. 24/7 MN incorporates comprehensive corporate communications resources and tools to engage the investment community. Visit 24/7 Market News website here.

24/7 MARKET NEWS, INC Disclaimer
Please go to https://247marketnews.com/disclaimer/ for disclaimer information.

CONTACT:
24/7 Market News
Editor@247marketnews.com

Related news for (XHLD, SKYQ, GNPX, XAIR, NTHD, TLPH)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.